Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by theNormon Oct 28, 2022 3:19pm
139 Views
Post# 35056656

UK's NHS best managed system

UK's NHS best managed system
Govt and hospital administrators the world over have generally failed to deliver for patients since covid began IMO. In my experience the UK under Boris J has performed away better than most, with the notable exception of not providing a very good example of adherence to restrictions. That aside even with the disaster of blood clots caused by Oxford's AZ vaccine they've pivoted multiple times to adapt to rapidly changing conditions and were among the first to loosen restrictions when Omicron proved to have a very low mortality rate. They used testing and contact tracing probably the best of western nations as well IMO. I have very confident NICE has reviewed VMS well and will see the tremendous savings and health benefits it offers and make us the new standard of care for most heart patients in the UK
<< Previous
Bullboard Posts
Next >>